Pulmonary Arterial Hypertension Clinical Trials in Providence, Rhode Island

4 studies are recruiting for pulmonary arterial hypertension in Providence, Rhode Island right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults

    Phase 1b/2 Study of HS235 Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of the Activin Signaling Inhibitor HS235 Added to Background Treatment in Adults with Pulmonary Arterial Hypertension (PAH)

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Investigational Site-104, Providence, Rhode Island
    Locations
    4 in total
    Run by
    35Pharma Inc

    See if you can join NCT07143448 on ClinicalTrials.gov

  2. A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

    Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lungs and overworks the heart. PAH can make it hard to breathe and be active. Some standard (usual) tre…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Rhode Island Hospital ( Site 1033), Providence, Rhode Island
    Locations
    136 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT07218029 on ClinicalTrials.gov

  3. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK…

    Stage
    Not phased
    Ages
    0 to 20
    Site
    Rhode Island Hospital, Providence, Rhode Island
    Locations
    52 in total
    Run by
    Duke University

    See if you can join NCT04278404 on ClinicalTrials.gov

  4. Pulmonary Hypertension Association Registry

    The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

    Stage
    Not phased
    Ages
    0 and older
    Site
    Rhode Island Hospital, Providence, Rhode Island
    Locations
    52 in total
    Run by
    Pulmonary Hypertension Association, Inc.

    See if you can join NCT04071327 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.